Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations

Nanomedicine (Lond). 2019 Apr;14(7):889-910. doi: 10.2217/nnm-2018-0289. Epub 2019 Mar 15.

Abstract

Aim: To prepare nanostructured lipid carriers (NLCs) loaded with asenapine maleate (ASPM) to increase its oral bioavailability by intestinal lymphatic uptake.

Materials & methods: ASPM-NLCs were prepared by ultrasound dispersion technique, by adopting Design of Experiment approach, and characterized.

Results: The optimized formulation exhibited good physicochemical parameters. Differential scanning calorimetry and x-ray diffraction studies indicated the amorphized nature of ASPM in lipid matrix. In vitro drug release study indicated the sustained release of drug from NLCs. ASPM-NLCs showed greater permeability across Caco2 cells and everted rat ileum. ASPM-NLCs showed greater cellular uptake, superior preclinical oral bioavailability and higher efficacy in reducing the L-DOPA-carbidopa-induced locomotor count compared with plain drug.

Conclusion: ASPM-NLCs were successfully developed that showed enhanced performance both in vitro and in vivo.

Keywords: imaging; Caco 2 cells; asenapine maleate; nanostructured lipid carriers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Biocompatible Materials / chemistry
  • Biological Availability
  • Biological Transport
  • Caco-2 Cells
  • Cell Survival / drug effects
  • Dibenzocycloheptenes
  • Drug Carriers / chemistry*
  • Drug Compounding / methods
  • Drug Liberation
  • Excipients / chemistry
  • Heterocyclic Compounds, 4 or More Rings / administration & dosage
  • Heterocyclic Compounds, 4 or More Rings / pharmacokinetics*
  • Humans
  • Lipids / chemistry*
  • Male
  • Maleates / chemistry*
  • Nanostructures / chemistry*
  • Particle Size
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution / drug effects
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Dibenzocycloheptenes
  • Drug Carriers
  • Excipients
  • Heterocyclic Compounds, 4 or More Rings
  • Lipids
  • Maleates
  • maleic acid
  • asenapine